Liver Lipodystrophy in Barraquer-Simons Syndrome: How Much Should We Worry About? [PDF]
Georgescu D +9 more
europepmc +1 more source
Postmarketing Surveillance of the Safety and Effectiveness of Metreleptin in Patients with Lipodystrophy in Japan. [PDF]
Ebihara K, Hata T, Sato Y, Miyano M.
europepmc +1 more source
Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to a Pathogenic <i>LMNA</i> Variant R482: Maternal Transmission to Non-Identical Twins. [PDF]
Duque-Cordoba PA +5 more
europepmc +1 more source
Impact of Juvenile Dermatomyositis on Growth, Puberty, Bone Mineral Density, and Body Composition in Children. [PDF]
Sudhera N +3 more
europepmc +1 more source
Leptin Therapy Improves Metabolic Dysfunction in Immune Checkpoint Inhibitor-induced Lipodystrophy. [PDF]
Vahidi Rad M +3 more
europepmc +1 more source
Lipolysis in Health and Disease: Pathways, Regulation, and Metabolic Consequences. [PDF]
Bordelon CL, Stephens JM.
europepmc +1 more source
Neonatal Sweet syndrome associated with a rectovestibular fistula in a 5-week-old female: A case report. [PDF]
Horth D, Auger I, Dionne MC.
europepmc +1 more source
Case Report: Generalized lipodystrophy following immune-checkpoint inhibitor therapy. [PDF]
Lee AH, Hui R, Gunton JE.
europepmc +1 more source
Maternal and fetal genetic predispositions to insulin deficiency and resistance affect fetal growth through distinct pathways. [PDF]
Yu G +15 more
europepmc +1 more source

